Association between Helicobacter pylori and Barrett's Esophagus: A case-control study

American Journal of Gastroenterology

Volumn 109, Issue 3, 2014, Pages 357-368

  Fischbach, Lori A ^a,b   Graham, David Y ^c   Kramer, Jennifer R ^d   Rugge, Massimo ^e   Verstovsek, Gordana ^d   Parente, Paola ^e   Alsarraj, Abeer ^c,d   Fitzgerald, Stephanie ^c,d   Shaib, Yasser ^c   Abraham, Neena S ^c,d   Kolpachi, Anna ^c   Gupta, Swapna ^c   Vela, Marcelo F ^c   Velez, Maria ^c   Cole, Rhonda ^c   Anand, Bhupinderjit ^c   El Serag, Hashem B ^c,d  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

STOMACH SECRETION INHIBITOR;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; COLONOSCOPY; CONTROLLED STUDY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK REDUCTION; STOMACH ACID SECRETION; STOMACH ATROPHY; STOMACH BIOPSY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; COLONOSCOPY; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84895790636     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.443     Document Type: Article

References (35)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in diff erent geographic regions of the world. J Clin Oncol 2006; 24: 2137-50.
2. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002; 11: 235-56.
3. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008; 100: 1184-7.
4. Naef AP, Savary M, Ozzello L. Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Th orac Cardiovasc Surg 1975; 70: 826-35.
5. Moghissi K, Sharpe D A, Pender D. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study. Eur J Cardiothorac Surg 1993; 7: 126-31.
6. Raghunath A, Hungin APS, Wooff D et al. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003; 326: 737.
7. Souza RC, Lima ma JH. H elicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship. Dis Esophagus 2009; 22: 256-63.
8. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res 2008; 1: 329-38.
9. El Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998; 43: 327-33.
10. Abe Y, Ohara S, Koike T et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol 2004; 99: 1222-5.
11. Wang F, Xia P, Wu F et al. Helicobacter pylori vacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells. J Biol Chem 2008; 283: 26714-25.
12. Raghunath A, Hungin PS, Wooff D et al. Prevalence of Helicobacter pylori in patients with gastro-oesphageal reflux disease: systematic review. BMJ 2003; 326: 736-9.
13. Cremonini F, Di Caro S, Delgado-Aros S et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Th er 2003; 18: 279-89.
14. Saad AM, Choudhary A, Bechtold ML. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastroenterol 2012; 47: 129-35.
15. Fischbach LA, Nordenstedt H, Kramer JR et al. The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter 2012; 17: 163-75.
16. Wang C, Yuan U, Hunt RH. Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis. Am J Gastroenterol 2009; 104: 492-500.
17. Rokkas T, Pistiolas D, Sechopoulos los P et al. relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroentero; Hepatol 2007; 5: 1413-7.
18. Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett's Esophagus: the Prague C &M criteria. Gastroenterol 2006; 131: 1392-9.
19. Rugge M, Meggio A, Pennelli G et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-66.
20. Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
21. Locke GR III, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56.
22. Harlan LC, Block G. Use of adjustment factors with a brief food frequency questionnaire to obtain nutrient values. Epidemiology 1990; 1: 224-31.
23. Rothman KL. Epidemiology: An introduction. Oxford University Press: New York, NY, 2002, pp 194.
24. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43-6.
25. Savitz DA, Olshan AF. Multiple comparisons and related issues in epidemiologic research. Am J Epidemiol 1995; 142: 904-8.
26. Sampliner RE. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-95.
27. Graham DY, Yamaoka Y. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter 1998; 3: 145-51.
28. Fujishima K, Misumi A, Akagi M. Histopathologic study on development and extension of atrophic change in the gastric mucosa. Gastroenterol Jpn 1984; 19: 9-17.
29. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis 2012; 13: 2-9.
30. Karnes WE, Samloff IM, Siurala M et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterol 1991; 101: 167-74.
31. Dickey W, Kenny BD, McConnell JB. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment Pharmacol Th er 1996; 10: 289-93.
32. Attumi TA, Graham DY. Follow-up testing after treatment of Helicobacter pylori infections: cautions, caveats, and recommendations. Clin Gastroenterol Hepatol 2011; 9: 373-5.
33. Rubenstein JH, Inadomi JM, Scheiman J et al. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol 2013; 3565: 1231-7.
34. Malaty HM, El-Kasabany A, Graham DY et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002; 359: 931-5.
35. Wang H, Steff en LM, Jacobs DR et al. Trends in cardiovascular risk factor levels in the Minnesota Heart Survey (1980-2002) as compared with the National Health and Nutrition Examination Survey (1976-2002): a partial explanation for Minnesota's low cardiovascular disease mortality? Am J Epidemiol 2011; 173: 526-38.